The surgical significance of residual mucosal abnormalities in rectal cancer following neoadjuvant chemoradiotherapy

British Journal of Surgery

Volumn 99, Issue 7, 2012, Pages 993-1001

  Smith, F M ^a,b   Chang, K H ^a,b   Sheahan, K ^b   Hyland, J ^a,b   O'Connell, P R ^a,b   Winter, D C ^a,b  

^a UNIVERSITY COLLEGE DUBLIN   (Ireland)

^b ST VINCENT S UNIVERSITY HOSPITAL   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84862755174     PISSN: 00071323     EISSN: 13652168     Source Type: Journal    
DOI: 10.1002/bjs.8700     Document Type: Article

References (38)

1. Improved survival with preoperative radiotherapy in resectable rectal cancer. Swedish Rectal Cancer Trial. N Engl J Med 1997; 336: 980-987.
2. Kapiteijn E, Marijnen CA, Nagtegaal ID, Putter H, SteupWH, Wiggers T et al.; Dutch Colorectal Cancer Group. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N Engl J Med 2001; 345: 638-646.
3. Sauer R, Becker H, HohenbergerW, Rödel C,Wittekind C, Fietkau R et al.; German Rectal Cancer Study Group. Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med 2004; 351: 1731-1740.
4. Beddy D, Hyland JM, Winter DC, Lim C, White A, Moriarty M et al. A simplified tumor regression grade correlates with survival in locally advanced rectal carcinoma treated with neoadjuvant chemoradiotherapy. Ann Surg Oncol 2008; 15: 3471-3477.
5. O'Neill BD, Brown G, Heald RJ, Cunningham D, Tait DM. Non-operative treatment after neoadjuvant chemoradiotherapy for rectal cancer. Lancet Oncol 2007; 8: 625-633. (Pubitemid 47008889)
6. Smith FM,Waldron D, Winter DC. Rectum-conserving surgery in the era of chemoradiotherapy. Br J Surg 2010; 97: 1752-1764.
7. Kuremsky JG, Tepper JE, McLeod HL. Biomarkers for response to neoadjuvant chemoradiation for rectal cancer. Int J Radiat Oncol Biol Phys 2009; 74: 673-688.
8. Perez RO. Predicting response to neoadjuvant treatment for rectal cancer: a step toward individualized medicine. Dis Colon Rectum 2011; 54: 1057-1058.
9. Smith FM, Gallagher WM, Fox E, Stephens RB, Rexhepaj E, Petricoin EF III et al. Combination of SELDI-TOF-MS and data mining provides early-stage response prediction for rectal tumors undergoing multimodal neoadjuvant therapy. Ann Surg 2007; 245: 259-266. (Pubitemid 46151655)
10. Smith FM, Reynolds JV, Kay EW, Crotty P, Murphy JO, Hollywood D et al. COX-2 overexpression in pretreatment biopsies predicts response of rectal cancers to neoadjuvant radiochemotherapy. Int J Radiat Oncol Biol Phys 2006; 64: 466-472. (Pubitemid 43083434)
11. Kalady MF, de Campos-Lobato LF, Stocchi L, Geisler DP, Dietz D, Lavery IC et al. Predictive factors of pathologic complete response after neoadjuvant chemoradiation for rectal cancer. Ann Surg 2009; 250: 582-589.
12. Hüser N, Michalski CW, Erkan M, Schuster T, Rosenberg R, Kleeff J et al. Systematic review and meta-Analysis of the role of defunctioning stoma in low rectal cancer surgery. Ann Surg 2008; 248: 52-60.
13. Pucciarelli S, Del Bianco P, Efficace F, Serpentini S, Capirci C, De Paoli A et al. Patient-reported outcomes after neoadjuvant chemoradiotherapy for rectal cancer: a multicenter prospective observational study. Ann Surg 2011; 253: 71-77.
14. Bujko K, Sopylo R, Kepka L. Local excision after radio(chemo)therapy for rectal cancer: is it safe? Clin Oncol (R Coll Radiol) 2007; 19: 693-700. (Pubitemid 47471502)
15. Mignanelli ED, Campos-Lobato LF, Stocchi L, Lavery IC, Dietz DW. Downstaging after chemoradiotherapy for locally advanced rectal cancer: is there more (tumor) than meets the eye? Dis Colon Rectum 2010; 53: 251-256.
16. Read TE, Andujar JE, Caushaj PF, Johnston DR, Dietz DW, Myerson RJ et al. Neoadjuvant therapy for rectal cancer: histologic response of the primary tumor predicts nodal status. Dis Colon Rectum 2004; 47: 825-831. (Pubitemid 38702600)
17. Evans J, Patel U, Brown G. Rectal cancer: primary staging and assessment after chemoradiotherapy. Semin Radiat Oncol 2011; 21: 169-177.
18. Smith FM, Reynolds JV, Miller N, Stephens RB, Kennedy MJ. Pathological and molecular predictors of the response of rectal cancer to neoadjuvant radiochemotherapy. Eur J Surg Oncol 2006; 32: 55-64. (Pubitemid 43103989)
19. Meterissian S, Skibber J, Rich T, Roubein L, Ajani J, Cleary K et al. Patterns of residual disease after preoperative chemoradiation in ultrasound T3 rectal carcinoma. Ann Surg Oncol 1994; 1: 111-116.
20. Callender GG, Das P, Rodriguez-Bigas MA, Skibber JM, Crane CH, Krishnan S et al. Local excision after preoperative chemoradiation results in an equivalent outcome to total mesorectal excision in selected patients with T3 rectal cancer. Ann Surg Oncol 2010; 17: 441-447.
21. Glynne-Jones R, Wallace M, Livingstone JI, Meyrick-Thomas J. Complete clinical response after preoperative chemoradiation in rectal cancer: is a 'wait and see' policy justified? Dis Colon Rectum 2008; 51: 10-19.
22. Guerrieri M, Baldarelli M, Organetti L, Grillo Ruggeri F, Mantello G, Bartolacci S et al. Transanal endoscopic microsurgery for the treatment of selected patients with distal rectal cancer: 15 years experience. Surg Endosc 2008; 22: 2030-2035.
23. Habr-Gama A, Perez RO, Nadalin W, Sabbaga J, Ribeiro U Jr., Silva e Sousa AH Jr. et al. Operative versus nonoperative treatment for stage 0 distal rectal cancer following chemoradiation therapy: long-Term results. Ann Surg 2004; 240: 711-717.
24. Habr-Gama A, Perez RO, Wynn G, Marks J, Kessler H, Gama-Rodrigues J. Complete clinical response after neoadjuvant chemoradiation therapy for distal rectal cancer: characterization of clinical and endoscopic findings for standardization. Dis Colon Rectum 2010; 53: 1692-1698.
25. Sobin LH, Wittekind C. UICC TNM Classification of Malignant Tumours (5th edn).Wiley-Liss: New York, 1997.
26. Sobin LH, Wittekind C. UICC TNM Classification of Malignant Tumours (6th edn).Wiley-Blackwell: New York, 2002.
27. Sobin LH, Gospodarowicz MK, Wittekind C. UICC TNM Classification of Malignant Tumours (7th edn). Wiley-Blackwell: Oxford, 2009.
28. Kobayashi H, Mochizuki H, Kato T, Mori T, Kameoka S, Shirouzu K et al.; Study Group for Rectal Cancer Surgery of the Japanese Society for Cancer of the Colon and Rectum. Lymph node ratio is a powerful prognostic index in patients with stage III distal rectal cancer: a Japanese multicenter study. Int J Colorectal Dis 2011; 26: 891-896.
29. Bujko K, Richter P, Kolodziejczyk M, Nowacki MP, Kulig J, Popiela T et al.; Polish Colorectal Study Group. Preoperative radiotherapy and local excision of rectal cancer with immediate radical re-operation for poor responders. Radiother Oncol 2009; 92: 195-201.
30. Guillem JG, Chessin DB, Cohen AM, Shia J, Mazumdar M, EnkerWet al. Long-Term oncologic outcome following preoperative combined modality therapy and total mesorectal excision of locally advanced rectal cancer. Ann Surg 2005; 241: 829-836.
31. Kim CJ, Yeatman TJ, Coppola D, Trotti A, Williams B, Barthel JS et al. Local excision of T2 and T3 rectal cancers after downstaging chemoradiation. Ann Surg 2001; 234: 352-358.
32. Hiotis SP, Weber SM, Cohen AM, Minsky BD, Paty PB, Guillem JG et al. Assessing the predictive value of clinical complete response to neoadjuvant therapy for rectal cancer: an analysis of 488 patients. J Am Coll Surg 2002; 194: 131-135.
33. Valentini V, Aristei C, Glimelius B, Minsky BD, Beets-Tan R, Borras JM et al. Multidisciplinary Rectal Cancer Management: 2nd European Rectal Cancer Consensus Conference (EURECA-CC2). Radiother Oncol 2009; 92: 148-63.
34. Chalian H, Töre HG, Horowitz JM, Salem R, Miller FH, Yaghmai V. Radiologic assessment of response to therapy: comparison of RECIST Versions 1.1 and 1.0. Radiographics 2011; 31: 2093-2105.
35. Kim E, Hwang JM, Garcia-Aguilar J. Local excision for rectal carcinoma. Clin Colorectal Cancer 2008; 7: 376-385.
36. Das P, Skibber JM, Rodriguez-Bigas MA, Feig BW, Chang GJ, Hoff PM et al. Clinical and pathologic predictors of locoregional recurrence, distant metastasis, and overall survival in patients treated with chemoradiation and mesorectal excision for rectal cancer. Am J Clin Oncol 2006; 29: 219-224. (Pubitemid 44270928)
37. Kim NK, Kim YW, Min BS, Lee KY, Sohn SK, Cho CH. Factors associated with local recurrence after neoadjuvant chemoradiation with total mesorectal excision for rectal cancer. World J Surg 2009; 33: 1741-1749.
38. Kikuchi R, Takano M, Takagi K, Fujimoto N, Nozaki R, Fujiyoshi T et al. Management of early invasive colorectal cancer. Risk of recurrence and clinical guidelines. Dis Colon Rectum 1995; 38: 1286-1295.